Detalhe da pesquisa
1.
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.
Eur Heart J
; 33(7): 846-56, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22112961
2.
Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice.
J Cereb Blood Flow Metab
; 33(4): 490-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23250107